Pre-Open Stock Movers 08/10: (CLNE) (OCN) (HRTX) (YELP) Higher; (GEVO) (SPWR) (MYGN) (PRGO) Lower (more...)

August 10, 2016 9:28 AM EDT

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Today's Pre-Open Stock Movers

Gevo (NASDAQ: GEVO) 30% LOWER; reported Q2 EPS of ($0.15), versus ($0.66) reported last year. Revenue for the quarter came in at $8.11 million, versus $8.9 million reported last year.

SunPower (NASDAQ: SPWR) 30% LOWER; reported Q2 EPS of ($0.22), $0.02 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $420.5 million versus the consensus estimate of $345.08 million. GUIDANCE: SunPower sees FY2016 revenue of $3-3.2 billion, versus the consensus of $3.3 billion. Also sees gross margin of 10.5 percent to 12.5 percent, EBITDA of $275 million to $325 million, capital expenditures of $225 million to $245 million and gigawatts deployed in the range of 1.45 GW to 1.65 GW. Also announces workforce reduction of approximately 15 percent or 1,200 employees, primarily related to its Philippine facility closure.

Myriad Genetics (NASDAQ: MYGN) 22.3% LOWER; reported Q4 EPS of $0.32, $0.06 worse than the analyst estimate of $0.38. Revenue for the quarter came in at $186.5 million versus the consensus estimate of $187.92 million. GUIDANCE: Myriad Genetics sees Q1 2017 EPS of $0.25-$0.27, versus the consensus of $0.43. Myriad Genetics sees Q1 2017 revenue of $167-170 million, versus the consensus of $192.0 million. Myriad Genetics sees FY2017 EPS of $1.00-$1.10, versus the consensus of $1.65. Myriad Genetics sees FY2017 revenue of $740-760 million, versus the consensus of $755.5 million.

Tidewater (NYSE: TDW) 19.5% LOWER; reported Q1 EPS of ($1.89), may not compare to the analyst estimate of ($0.74). Revenue for the quarter came in at $167.9 million versus the consensus estimate of $169.75 million. Updates Status of Discussions with Lenders and Noteholders

Clean Energy Fuels (NASDAQ: CLNE) 17.9% HIGHER; reported Q2 EPS of $0.03, $0.17 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $108 million versus the consensus estimate of $94.33 million.

Ocwen Financials (NYSE: OCN) 16.5% HIGHER; adds to intra-day gains after S&P Global Ratings raised its overall rankings on Ocwen Loan Servicing LLC (Ocwen) to AVERAGE from BELOW AVERAGE as a residential mortgage primary, subprime, special, and subordinate-lien servicer.

Heron Therapeutics, Inc. (NASDAQ: HRTX) 16% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has approved SUSTOLĀ® (granisetron) extended-release injection. SUSTOL is a serotonin-3 (5-HT3) receptor antagonist indicated in combination with other antiemetics in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (MEC) or anthracycline and cyclophosphamide (AC) combination chemotherapy regimens.

Perrigo (NYSE: PRGO) 12.6% LOWER; reported Q2 EPS of $1.93, $0.05 worse than the analyst estimate of $1.98. Revenue for the quarter came in at $1.48 billion versus the consensus estimate of $1.43 billion. GUIDANCE: Perrigo now sees FY2016 EPS of $6.85-$7.15, versus the consensus of $8.19. The company notes revised expectations for the Rx segment on the adjustment

Yelp (NYSE: YELP) 12% HIGHER; reported Q2 EPS of $0.01, $0.08 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $173.4 million versus the consensus estimate of $169.82 million. GUIDANCE: Yelp sees Q3 2016 revenue of $180-184 million, versus the consensus of $179.7 million. Yelp sees FY2016 revenue of $700-708 million, versus the consensus of $699.8 million.

JD.com (NASDAQ: JD) 9.9% HIGHER; reported Q2 EPS of $0.04, $0.07 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $9.8 billion versus the consensus estimate of $9.81 billion.

Diplomat Pharmacy (NYSE: DPLO) 7.6% LOWER; reported Q2 EPS of $0.23, $0.02 better than the analyst estimate of $0.21. Revenue for the quarter came in at $1.09 billion versus the consensus estimate of $1.12 billion. GUIDANCE: Diplomat Pharmacy sees FY2016 EPS of $0.90-$0.95, versus prior guidance of $0.88-$0.95 and the consensus of $0.93. Diplomat Pharmacy sees FY2016 revenue of $4.5-4.9 billion, versus the consensus of $4.76 billion.

Ralph Lauren (NYSE: RL) 6.5% HIGHER; reported Q1 EPS of $1.06, $0.17 better than the analyst estimate of $0.89. Revenue for the quarter came in at $1.55 billion versus the consensus estimate of $1.53 billion.

DHT Holdings (NYSE: DHT) 6% HIGHER; reported Q2 EPS of $0.34, $0.04 better than the analyst estimate of $0.30. Revenue for the quarter came in at $83.2 million versus the consensus estimate of $82.44 million.

Halozyme Therapeutics (NASDAQ: HALO) 5.8% HIGHER; reported Q2 EPS of ($0.21), $0.06 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $33.3 million versus the consensus estimate of $29.94 million. GUIDANCE: Halozyme Therapeutics sees FY2016 revenue of $140-150 million, versus prior guidance of $130-145 million and the consensus of $136.7 million.

Lattice Semiconductor (NASDAQ: LSCC) 5.7% LOWER; reported Q2 EPS of $0.00, $0.02 worse than the analyst estimate of $0.02. Revenue for the quarter came in at $99.2 million versus the consensus estimate of $100.07 million.

Energous (NASDAQ: WATT) 5.7% HIGHER; reported Q2 EPS of ($0.62), in-line with the analyst estimate of ($0.62). Revenue for the quarter came in at $200 thousand versus the consensus estimate of $300 thousand. Reiterated its previous forecast for exiting the third quarter of 2017 at a monthly cash flow break even run rate.

Fossil Group (NASDAQ: FOSL) 5.4% HIGHER; reported Q2 EPS of $0.12, $0.03 better than the analyst estimate of $0.09. Revenue for the quarter came in at $685 million versus the consensus estimate of $671.86 million. GUIDANCE: Fossil Group sees Q3 2016 EPS of $0.15-$0.40, versus the consensus of $0.68.

CyberArk Software (NASDAQ: CYBR) 4.9% LOWER; reported Q2 EPS of $0.29, $0.09 better than the analyst estimate of $0.20. Revenue for the quarter came in at $50.4 million versus the consensus estimate of $48.25 million. GUIDANCE: CyberArk Software sees Q3 2016 EPS of $0.21-$0.23, versus the consensus of $0.21. CyberArk Software sees Q3 2016 revenue of $51.5-52.5 million, versus the consensus of $52.0 million. CyberArk Software sees FY2016 EPS of $1.03-$1.07, versus the consensus of $0.92. CyberArk Software sees FY2016 revenue of $210.5-212.5 million, versus the consensus of $210.9 million.

Eldorado Gold Corp (NYSE: EGO) 4.4% HIGHER; Goldman Sachs upgraded from Neutral to Buy

Wendy's (NASDAQ: WEN) 4.3% LOWER; reported Q2 EPS of $0.10, $0.01 better than the analyst estimate of $0.09. Revenue for the quarter came in at $382.7 million versus the consensus estimate of $367.67 million. Same-restaurant sales increased 0.4 percent at North America system restaurants in the second quarter of 2016. On a two-year basis, second-quarter 2016 same-restaurant sales increased 2.6 percent for the North America system. GUIDANCE: Wendy's sees FY2016 EPS of $0.39-$0.40, versus prior guidance of $0.38-$0.40 and the consensus of $0.39.

The Container Store Group (NYSE: TCS) 4.1% HIGHER; reported Q1 EPS of ($0.04), versus ($0.12) reported last year. Revenue for the quarter came in at $177.4 million, versus $169.96 million reported last year. GUIDANCE: The Container Store Group maintains FY2016 EPS of $0.20-$0.30. The Container Store Group maintains FY2016 revenue of $830-845 million.

First Solar (NASDAQ: FSLR) 4% LOWER; down with SPWR.

Galena Biopharma (NASDAQ: GALE) 4% LOWER; reported Q2 EPS of $0.05, $0.11 better than the analyst estimate of ($0.06).

United States Steel Corporation (NYSE: X) 3.7% LOWER; announced that it has priced its underwritten public offering of approximately 18,900,000 shares of common stock, which was upsized from the previously announced 17,000,000 at a public offering price of $23 per share, for gross proceeds of approximately $434.7 million

SolarEdge Technologies (NASDAQ: SEDG) 3.4% LOWER; reported Q4 EPS of $0.44, $0.03 better than the analyst estimate of $0.41. Revenue for the quarter came in at $124.8 million versus the consensus estimate of $129.49 million. GUIDANCE: SolarEdge Technologies sees Q1 2017 revenue of $130-139 million, versus the consensus of $136.9 million. Gross margins to be within the range of 30% to 32%.

Cliffs Natural Resources Inc. (NYSE: CLF) 3.1% LOWER; announced the commencement of an underwritten public offering of $300 million of its common shares ("Common Shares") or up to an aggregate of $345 million of Common Shares if the underwriters exercise their option to purchase additional Common Shares in full (the "Offering").

Michael Kors (NYSE: KORS) 2.9% LOWER; reported Q1 EPS of $0.88, $0.14 better than the analyst estimate of $0.74. Revenue for the quarter came in at $987.9 million versus the consensus estimate of $953.04 million. Michael Kors sees Q2 2017 EPS of $0.84-$0.88, versus the consensus of $1.03. Michael Kors sees Q2 2017 revenue of $1.07-1.085 billion, versus the consensus of $1.11 billion. Michael Kors sees FY2017 EPS of $4.56-$4.64, versus the consensus of $4.60.

SLM Corp. (NASDAQ: SLM) 2.3% HIGHER; Goldman Sachs adds to Conviction Buy List.

Intrexon (NYSE: XON) 1.7% LOWER; reported Q2 EPS of ($0.42), may not compare to the analyst estimate of ($0.26). Revenue for the quarter came in at $52.5 million versus the consensus estimate of $53.78 million.

Mylan (NASDAQ: MYL) 1.6% LOWER; reported Q2 EPS of $1.16, $0.02 better than the analyst estimate of $1.14. Revenue for the quarter came in at $2.56 billion versus the consensus estimate of $2.57 billion.

Disney (NYSE: DIS) 1.6% LOWER; reported Q3 EPS of $1.62, $0.01 better than the analyst estimate of $1.61. Revenue for the quarter came in at $14.28 billion versus the consensus estimate of $14.15 billion.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Special Reports

Related Entities

Goldman Sachs Conviction Buy List, Goldman Sachs, Standard & Poor's, Layoffs, Pre-Open Losers, Pre-Open Winners, Pre Market Movers

Add Your Comment